— Item 3 of 13 mY wax <q Se i @ al Lo) id @A &s

Question Id: 526 Previous Next Full Screen Tutorial Lab Values Notes Calculator Reverse Color Text Zoom Settings

Researchers develop a novel agent to treat extrinsic asthma. In a clinical trial, patients with
moderate to severe asthma treated with this medication experience fewer exacerbations.
They are found to have lower levels of serum IgE, even after exposure to triggering allergens.

This medication helps improve asthma symptoms by binding and inhibiting the substance
produced by sensitized Th2 cells in the airways that promotes immunoglobulin isotype
switching in B lymphocytes. Which of the following is the most likely target of this medication?

©) A. Interleukin-1
©) B. Interleukin-3
©) C. Interleukin-4
©) D. Interleukin-5
©) E. Interferon-gamma

(> F. Transforming growth factor-beta

Activate Windows

Block Time Elapse

Tutor Feedback id = End Block
